TrialAesthetic surgery journal2026
Therapeutic Efficacy and Safety of Recombinant Botulinum Toxin Type A for Moderate to Severe Glabellar Lines: A Randomized, Controlled, Double-blind, Phase III Trial in Chinese Adults.
Yan Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.